Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01431183
Other study ID # 5U01IP000132
Secondary ID
Status Completed
Phase N/A
First received September 6, 2011
Last updated September 7, 2011
Start date October 2008
Est. completion date December 2010

Study information

Verified date September 2011
Source University of Michigan
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective of this study was to assess the feasibility and effectiveness of using a statewide immunization information system (IIS) to send seasonal influenza vaccine reminders from Local Health Departments (LHDs), targeting children with high-risk conditions.


Recruitment information / eligibility

Status Completed
Enrollment 3618
Est. completion date December 2010
Est. primary completion date February 2009
Accepts healthy volunteers No
Gender Both
Age group 24 Months to 60 Months
Eligibility Inclusion Criteria:

- children, 24-60 months

- current or previous enrollment in Medicaid (Michigan)

- presence of at least 1 chronic condition, as indicated by the Michigan Care Improvement Registry (MCIR)

- resident of Kalamazoo, Ottawa, or Kent counties (Michigan)

Exclusion Criteria:

- receipt of influenza prior to notification date

- ineligible for reminder/recall notification in the Michigan Care Improvement Registry (MCIR)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Behavioral:
Mailed influenza vaccination reminder notice
Influenza vaccination reminder sent by postal mail

Locations

Country Name City State
United States University of Michigan, Child Health Evaluation and Research Unit Ann Arbor Michigan

Sponsors (2)

Lead Sponsor Collaborator
University of Michigan Centers for Disease Control and Prevention

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary seasonal influenza vaccination Receipt of 1 or more dose of seasonal influenza vaccine, either trivalent inactivated influenza vaccine (TIV) or live attenuated influenza vaccine (LAIV) up to 4 months following reminder notification No
Secondary invalid mailing address Postal mailing address determined to be invalid for mail delivery, either by physical return of mailed reminder notification, or through the United States Postal Service's National Change of Address (NCOA) process up to 4 months following reminder notification No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05129436 - Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)